Martin Gramatzki

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Lennart Philippen, Natalie Schub, Andreas Günther, Gunnar Cario, Martin Schrappe, Roland Repp, Martin Gramatzki
Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease. Bone marrow transplantation (2023)
Francesca Gay, Andreas Günther, Massimo Offidani, Monika Engelhardt, Marco Salvini, Vittorio Montefusco, Francesca Patriarca, Sara Aquino, Wolfram Pönisch, Stefano Spada, Natalie Schub, Silvia Gentili, Ralph Wäsch, Paolo Corradini, Christian Straka, Antonio Palumbo, Hermann Einsele, Mario Boccadoro, Pieter Sonneveld, Martin Gramatzki
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network. Cancer 127 (18) (2021)
Mohamed A Kharfan-Dabaja, Myriam Labopin, Eolia Brissot, Nicolaus Kröger, Jürgen Finke, Fabio Ciceri, Erick Deconinck, Didier Blaise, Patrice Chevallier, Martin Gramatzki, Arnold Ganser, Matthias Stelljes, Matthias Edinger, Bipin Savani, Annalisa Ruggeri, Jaime Sanz, Arnon Nagler, Mohamad Mohty
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia. British journal of haematology 193 (3) (2021)

Martin Gramatzki.css-eqlu8i{font-size:small;padding-left:4px;}